Iridex regains Nasdaq listing compliance

5 hours ago 1

Ophthalmic medical technology company, Iridex (NASDAQ:IRIX) on Tuesday said that it has received formal notice from Nasdaq confirming it has regained compliance with continued listing standards.
The company had previously received a non-compliance notice on May 14, 2025, related to stockholders’ equity requirements